Strategic partnerships Leverage ongoing collaborations with pharmaceutical and animal-free protein players and expand co-development opportunities with Huvepharma and ADIO-backed initiatives to accelerate market reach in alt-protein ingredients for food and beverage brands.

Scale opportunities capitalize on the recent Series D funding and expansion announcements to secure multi-year supplier or co-manufacturing contracts with major U.S. retailers like Walmart and global brands seeking animal-free protein solutions for bars, beverages, bakery, and alt-meat applications.

Product portfolio Position the fermentation-based egg proteins and other versatile proteins as premium, nature-equivalent ingredients to win-sell into categories with high protein demand and clean-label trends, addressing both foodservice and consumer packaged goods fans seeking sustainable protein boosts.

Global expansion Target geographic markets enabled by Abu Dhabi investment and press coverage by healthtech and agtech outlets to pursue regional pilots and co-production deals, especially in regions prioritizing protein resilience and reduced environmental footprint.

Risk-aware selling Monitor the ongoing Onego Bio legal matter and position risk disclosures proactively when pitching to potential customers, while emphasizing the company’s strong capital backing and proven capacity expansion to reassure buyers about supply reliability.